Delving into the Latest Updates on Cytokine-Induced Memory-Like Natural Killer Cells(Cincinnati Children's Hospital Medical Center) with Synapse

Overview

Basic Info

Drug Type

CIK therapy

Synonyms

CIML-NK

Target-

Mechanism-

Therapeutic Areas

NeoplasmsHemic and Lymphatic Diseases

Active Indication

Acute Myeloid Leukemia

Inactive Indication-

Originator Organization

Cincinnati Children's Hospital Medical Center

Active Organization

Cincinnati Children's Hospital Medical Center

Inactive Organization-

Drug Highest PhasePhase 1/2

First Approval Date-

Regulation-

Login to view timeline

The objective of this study is to demonstrate that cytokine-induced memory-like natural killer cells can be generated from donor cells and infused safely into patients with relapsed or refractory acute myeloid leukemia (AML). A secondary objective is to assess efficacy of the CIML-NK cells in treating AML.

Start Date05 May 2023

Sponsor / Collaborator

Cincinnati Children's Hospital Medical Center

100 Clinical Results associated with Cytokine-Induced Memory-Like Natural Killer Cells(Cincinnati Children's Hospital Medical Center)

Login to view more data

100 Translational Medicine associated with Cytokine-Induced Memory-Like Natural Killer Cells(Cincinnati Children's Hospital Medical Center)

Login to view more data

100 Patents (Medical) associated with Cytokine-Induced Memory-Like Natural Killer Cells(Cincinnati Children's Hospital Medical Center)

Login to view more data

100 Deals associated with Cytokine-Induced Memory-Like Natural Killer Cells(Cincinnati Children's Hospital Medical Center)

Login to view more data